A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney

Yuki Abe, Takashi Sato, Masaki Takagi, Toru Watanabe, Yoshihisa Nagayama, Tomonobu Hasegawa, Tokinari Abe

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Rabson-Mendenhall syndrome (RMS) is a genetic disorder characterized by severe insulin resistance and somatic characteristics. Recombinant insulin-like growth factor 1 (r-IGF-1) is used to treat RMS, as the IGF-1 and insulin receptors share homology. However, the effect of r-IGF-1 varies in patients and it is difficult to manage metabolic status appropriately in r-IGF-1 resistant cases. We report a Japanese boy with RMS who showed resistance to r-IGF-1 therapy and a novel mutation in the insulin receptor in the tyrosine kinase domain. Mutations in this region disturb tyrosine kinase catalytic activity in IGF-1 receptors as a result of dominant negative effects. We consider this mutation to be the cause of resistance to r-IGF-1. The patient also exhibited radiographical features of medullary sponge kidney and had severe nephrocalcinosis and hypokalemia, indicating Bartter syndrome. However, analysis revealed no mutations in the responsible genes and the etiology of the renal abnormalities therefore remains unknown.

Original languageEnglish
Pages (from-to)587-590
Number of pages4
JournalJournal of Pediatric Endocrinology and Metabolism
Volume25
Issue number5-6
DOIs
Publication statusPublished - 2012 Jun 1

Fingerprint

Donohue Syndrome
Medullary Sponge Kidney
Somatomedins
Mutation
IGF Type 1 Receptor
Genes
Bartter Syndrome
Nephrocalcinosis
Inborn Genetic Diseases
Hypokalemia
Insulin Receptor
Protein-Tyrosine Kinases
Insulin Resistance
insulin receptor tyrosine kinase
Kidney

Keywords

  • Insulin receptor
  • Insulin-like growth factor 1
  • Medullary sponge kidney
  • Rabson-Mendenhall syndrome
  • Tyrosine kinase domain

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney. / Abe, Yuki; Sato, Takashi; Takagi, Masaki; Watanabe, Toru; Nagayama, Yoshihisa; Hasegawa, Tomonobu; Abe, Tokinari.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 25, No. 5-6, 01.06.2012, p. 587-590.

Research output: Contribution to journalArticle

@article{faec1545184e4653b0181b7e8fb32080,
title = "A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney",
abstract = "Rabson-Mendenhall syndrome (RMS) is a genetic disorder characterized by severe insulin resistance and somatic characteristics. Recombinant insulin-like growth factor 1 (r-IGF-1) is used to treat RMS, as the IGF-1 and insulin receptors share homology. However, the effect of r-IGF-1 varies in patients and it is difficult to manage metabolic status appropriately in r-IGF-1 resistant cases. We report a Japanese boy with RMS who showed resistance to r-IGF-1 therapy and a novel mutation in the insulin receptor in the tyrosine kinase domain. Mutations in this region disturb tyrosine kinase catalytic activity in IGF-1 receptors as a result of dominant negative effects. We consider this mutation to be the cause of resistance to r-IGF-1. The patient also exhibited radiographical features of medullary sponge kidney and had severe nephrocalcinosis and hypokalemia, indicating Bartter syndrome. However, analysis revealed no mutations in the responsible genes and the etiology of the renal abnormalities therefore remains unknown.",
keywords = "Insulin receptor, Insulin-like growth factor 1, Medullary sponge kidney, Rabson-Mendenhall syndrome, Tyrosine kinase domain",
author = "Yuki Abe and Takashi Sato and Masaki Takagi and Toru Watanabe and Yoshihisa Nagayama and Tomonobu Hasegawa and Tokinari Abe",
year = "2012",
month = "6",
day = "1",
doi = "10.1515/jpem-2011-0473",
language = "English",
volume = "25",
pages = "587--590",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "5-6",

}

TY - JOUR

T1 - A case of Rabson-Mendenhall syndrome with a novel mutation in the tyrosine kinase domain of the insulin receptor gene complicated by medullary sponge kidney

AU - Abe, Yuki

AU - Sato, Takashi

AU - Takagi, Masaki

AU - Watanabe, Toru

AU - Nagayama, Yoshihisa

AU - Hasegawa, Tomonobu

AU - Abe, Tokinari

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Rabson-Mendenhall syndrome (RMS) is a genetic disorder characterized by severe insulin resistance and somatic characteristics. Recombinant insulin-like growth factor 1 (r-IGF-1) is used to treat RMS, as the IGF-1 and insulin receptors share homology. However, the effect of r-IGF-1 varies in patients and it is difficult to manage metabolic status appropriately in r-IGF-1 resistant cases. We report a Japanese boy with RMS who showed resistance to r-IGF-1 therapy and a novel mutation in the insulin receptor in the tyrosine kinase domain. Mutations in this region disturb tyrosine kinase catalytic activity in IGF-1 receptors as a result of dominant negative effects. We consider this mutation to be the cause of resistance to r-IGF-1. The patient also exhibited radiographical features of medullary sponge kidney and had severe nephrocalcinosis and hypokalemia, indicating Bartter syndrome. However, analysis revealed no mutations in the responsible genes and the etiology of the renal abnormalities therefore remains unknown.

AB - Rabson-Mendenhall syndrome (RMS) is a genetic disorder characterized by severe insulin resistance and somatic characteristics. Recombinant insulin-like growth factor 1 (r-IGF-1) is used to treat RMS, as the IGF-1 and insulin receptors share homology. However, the effect of r-IGF-1 varies in patients and it is difficult to manage metabolic status appropriately in r-IGF-1 resistant cases. We report a Japanese boy with RMS who showed resistance to r-IGF-1 therapy and a novel mutation in the insulin receptor in the tyrosine kinase domain. Mutations in this region disturb tyrosine kinase catalytic activity in IGF-1 receptors as a result of dominant negative effects. We consider this mutation to be the cause of resistance to r-IGF-1. The patient also exhibited radiographical features of medullary sponge kidney and had severe nephrocalcinosis and hypokalemia, indicating Bartter syndrome. However, analysis revealed no mutations in the responsible genes and the etiology of the renal abnormalities therefore remains unknown.

KW - Insulin receptor

KW - Insulin-like growth factor 1

KW - Medullary sponge kidney

KW - Rabson-Mendenhall syndrome

KW - Tyrosine kinase domain

UR - http://www.scopus.com/inward/record.url?scp=84865643119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865643119&partnerID=8YFLogxK

U2 - 10.1515/jpem-2011-0473

DO - 10.1515/jpem-2011-0473

M3 - Article

VL - 25

SP - 587

EP - 590

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - 5-6

ER -